US 10968452
Polynucleotide agents targeting aminolevulinic acid synthase-1 (ALAS1) and uses thereof
granted A61KA61K31/712A61K47/549
Quick answer
US patent 10968452 (Polynucleotide agents targeting aminolevulinic acid synthase-1 (ALAS1) and uses thereof) held by Alnylam Pharmaceuticals, Inc. expires Mon Apr 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Apr 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K31/712, A61K47/549, A61K9/0019, A61K9/1272